$0.00050
0.000.00%
Pre-Market: Dec 23, 8:00 AM EDT
Comments
Loading...
Evelo Biosciences Insider Trading Activity | OTC:EVLO | Benzinga
Track the latest Evelo Biosciences insider trading activity. Stay informed on recent buys, sells, and market impact for Evelo Biosciences stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Evelo Biosciences Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Evelo Biosciences Inc
Shares Outstanding
18.983M
Insider Shares Owned
533.083K
Insider Percentage Owned
2.81%
Institutional Shares Held
347.000
Institutional Percentage Held
0.00%
| Nov 08, 2023 | Mark Bodmer | CSO, PRESIDENT R&D | 3.46K | $0.33 | -$1.04K | SELL-OPTIONS | 15.55% | 25.73K | Nov 07 - Nov 08 | View |
| Nov 08, 2023 | Duncan McHale | CHIEF MEDICAL OFFICER | 3.40K | $0.33 | -$1.02K | SELL-OPTIONS | 25.00% | 16.98K | Nov 07 - Nov 08 | View |
| Nov 08, 2023 | Simba Gill | PRESIDENT & CEO | 1.00K | $0.33 | -$56.76 | SELL-OPTIONS | 5.97% | 17.76K | Nov 07 - Nov 08 | View |
| Nov 08, 2023 | Marella Thorell | CHIEF FINANCIAL OFFICER | 4.69K | $0.33 | -$597.63 | SELL-OPTIONS | 26.69% | 22.26K | Nov 07 - Nov 08 | View |
| Nov 03, 2023 | Mark Bodmer | CSO, PRESIDENT R&D | 5.65K | $0.33 | -$2.26K | SELL-OPTIONS | 33.96% | 22.27K | Nov 01 - Nov 02 | View |
| Nov 03, 2023 | Duncan McHale | CHIEF MEDICAL OFFICER | 5.65K | $0.33 | -$2.26K | SELL-OPTIONS | 71.10% | 13.59K | Nov 01 - Nov 02 | View |
| Nov 03, 2023 | Marella Thorell | CHIEF FINANCIAL OFFICER | 8.50K | $0.33 | -$1.32K | SELL-OPTIONS | 93.74% | 17.57K | Nov 01 - Nov 02 | View |
| Sep 29, 2023 | Simba Gill | PRESIDENT & CEO | 13.00K | $3.94 | -$7.86K | SELL-OPTIONS | 346.40% | 16.76K | Sep 27 - Sep 28 | View |
| Aug 09, 2023 | Mark Bodmer | CSO, PRESIDENT R&D | 3.50K | $9.51 | -$29.75K | SELL-OPTIONS | 26.64% | 16.62K | Aug 07 - Aug 08 | View |
| Aug 09, 2023 | Simba Gill | PRESIDENT & CEO | 829.00 | $9.51 | -$3.25K | SELL-OPTIONS | 28.34% | 3.75K | Aug 07 - Aug 08 | View |
| Aug 09, 2023 | Duncan McHale | CHIEF MEDICAL OFFICER | 3.07K | $9.51 | -$32.66K | SELL-OPTIONS | 62.89% | 7.94K | Aug 07 - Aug 08 | View |
| Aug 09, 2023 | Marella Thorell | CHIEF FINANCIAL OFFICER | 4.50K | $9.51 | -$19.06K | SELL-OPTIONS | 98.32% | 9.07K | Aug 07 - Aug 08 | View |
| Jul 13, 2023 | Flagship Ventures Fund IV General Partner LLCFlagship Ventures Fund IV LPNutritional Health LTP Fund General Partner LLCNutritional Health LTP Fund LPFlagship Pioneering IncFlagship Pioneering Fund VII General Partner LLCFlagship Pioneering Fund VII LPNOUBAR AFEYAN | — | 5.41M | $2.31 | $12.50M | BUY | ∞ | 4.11M | Jul 11 | View |
| Jun 12, 2023 | Mark Bodmer | CSO, PRESIDENT R&D | -22.57K | $0.14 | -$3.20K | SELL | -7.92% | 262.56K | May 23 | View |
| May 10, 2023 | Duncan McHale | CHIEF MEDICAL OFFICER | -66.73K | $0.13 | -$8.37K | SELL | -40.63% | 97.52K | May 08 | View |
| May 10, 2023 | Mark Bodmer | CSO, PRESIDENT R&D | -68.01K | $0.13 | -$8.54K | SELL | -19.26% | 285.13K | May 08 | View |
| May 10, 2023 | Marella Thorell | CHIEF FINANCIAL OFFICER | -38.53K | $0.13 | -$4.84K | SELL | -29.64% | 91.47K | May 08 | View |
| May 10, 2023 | Simba Gill | PRESIDENT & CEO | -3.54K | $0.13 | -$443.89 | SELL | -5.70% | 58.51K | May 08 | View |
| Jan 23, 2023 | Stephen J Carriere | PRINCIPAL ACCOUNTING OFFICER | 203.00 | $1.06 | -$160.12 | SELL-OPTIONS | ∞ | 203.00 | Jan 19 - Jan 23 | View |
| Jun 01, 2022 | Flagship Ventures Fund IV General Partner LLCFlagship Ventures Fund IV LPFlagship Ventures Fund IVRx LPFlagship Ventures Opportunities Fund I General Partner LLCFlagship Ventures Opportunities Fund I LPNutritional Health LTP Fund General Partner LLCNutritional Health LTP Fund LPFlagship Pioneering IncNOUBAR AFEYAN | 10% OWNER | 27.40M | $1.46 | $40.00M | BUY | ∞ | 17.30M | May 27 | View |
| May 31, 2022 | Duncan McHale | CHIEF MEDICAL OFFICER | 34.25K | $1.46 | $50.00K | BUY | ∞ | 34.25K | May 27 | View |
| May 31, 2022 | Ara Darzi | DIRECTOR | 342.46K | $1.46 | $500.00K | BUY | ∞ | 342.46K | May 27 | View |
| May 31, 2022 | David R Epstein | DIRECTOR | 17.12K | $1.46 | $25.00K | BUY | 25.57% | 84.08K | May 27 | View |
| Feb 04, 2021 | Flagship Ventures Fund IV General Partner LLCFlagship Ventures Fund IV LPFlagship Ventures Fund IVRx LPFlagship Ventures Opportunities Fund I General Partner LLCFlagship Ventures Opportunities Fund I LPNutritional Health LTP Fund General Partner LLCNutritional Health LTP Fund LPNOUBAR AFEYAN | 10% OWNER | 130.00K | $15.00 | $1.95M | BUY | 1.71% | 7.72M | Feb 02 | View |
| Dec 14, 2020 | David R Epstein | — | 7.70K | $6.66 | $51.26K | PURCHASE | 77.00% | 17.70K | Dec 11 | View |
| Dec 02, 2020 | Xiaoli Liu | — | -3.00K | $5.17 | -$15.51K | SELL | -100.00% | 0.00 | Dec 01 | View |
| Sep 01, 2020 | David R Epstein | — | 10.00K | $4.44 | $44.44K | PURCHASE | ∞ | 10.00K | Aug 28 - Aug 31 | View |
| Jul 01, 2020 | Flagship Ventures Fund IV General Partner LLCFlagship Ventures Fund IV LPFlagship Ventures Fund IVRx LPFlagship Ventures Opportunities Fund I General Partner LLCFlagship Ventures Opportunities Fund I LPNOUBAR AFEYAN | — | 4.67M | $3.75 | $17.50M | PURCHASE | 155.01% | 7.68M | Jun 29 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.